WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011144640) NOVEL C3C EPITOPE, ANTIBODIES BINDING THERETO, AND USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/144640    International Application No.:    PCT/EP2011/058007
Publication Date: 24.11.2011 International Filing Date: 17.05.2011
Chapter 2 Demand Filed:    10.03.2012    
IPC:
C07K 16/18 (2006.01), G01N 33/564 (2006.01)
Applicants: SYDDANSK UNIVERSITET [DK/DK]; Campusvej 55 DK-5230 Odense M (DK) (For All Designated States Except US).
SKJOEDT, Mikkel, Ole [DK/DK]; (DK) (For US Only).
VITVED, Lars [DK/DK]; (DK) (For US Only).
PALARASAH, Yaseelan [IN/DK]; (DK) (For US Only)
Inventors: SKJOEDT, Mikkel, Ole; (DK).
VITVED, Lars; (DK).
PALARASAH, Yaseelan; (DK)
Agent: ORSNES, Henrik; Forskerparken 10 DK-5230 Odense M (DK)
Priority Data:
61/345,816 18.05.2010 US
Title (EN) NOVEL C3C EPITOPE, ANTIBODIES BINDING THERETO, AND USE THEREOF
(FR) NOUVEL ÉPITOPE SUR LE C3C, ANTICORPS S'Y LIANT ET LEUR UTILISATION
Abstract: front page image
(EN)Provided are antibodies directed against a novel epitope on the human C3c (complement factor 3 c) and the use and manufacture thereof. Moreover, there is provided a novel immunogen for use in the preparation of the antibodies. The antibodies are in the first place of the monoclonal type.
(FR)La présente invention concerne des anticorps dirigés contre un nouvel épitope sur le C3c humain (facteur 3 c du complément) ainsi que leur utilisation et fabrication. En outre, l'invention concerne un nouvel immunogène à utiliser dans la préparation desdits anticorps. Ces anticorps sont en premier lieu du type monoclonal.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)